Patients getting access to expensive gene therapies is just one of the many challenges to bringing these sometimes life-saving drugs to market.

A well-designed pharmacy network strategy offers the right in-network pharmacy coverage to account for population size, geographic area, clinical goals, and utilization patterns.

Accelerating the progress of biosimilars is key to lowering drug costs and improving patient access to potentially life-saving therapies.